BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takahashi Y, Kawate S, Watanabe M, Fukushima J, Mori S, Fukusato T. Amplification of c-myc and cyclin D1 genes in primary and metastatic carcinomas of the liver. Pathol Int. 2007;57:437-442. [PMID: 17587243 DOI: 10.1111/j.1440-1827.2007.02120.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Ye D, Luo H, Lai Z, Zou L, Zhu L, Mao J, Jacob T, Ye W, Wang L, Chen L. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells. Sci Rep 2016;6:30276. [PMID: 27451945 DOI: 10.1038/srep30276] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
2 Chung KY, Cheng IK, Ching AK, Chu JH, Lai PB, Wong N. Block of proliferation 1 (BOP1) plays an oncogenic role in hepatocellular carcinoma by promoting epithelial-to-mesenchymal transition. Hepatology. 2011;54:307-318. [PMID: 21520196 DOI: 10.1002/hep.24372] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
3 In der Stroth L, Tharehalli U, Günes C, Lechel A. Telomeres and Telomerase in the Development of Liver Cancer. Cancers (Basel) 2020;12:E2048. [PMID: 32722302 DOI: 10.3390/cancers12082048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
4 Hasegawa D, Wallace MC, Friedman SL. Stellate Cells and Hepatic Fibrosis. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 41-62. [DOI: 10.1016/b978-0-12-800134-9.00004-x] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bickenbach K, Galka E, Roggin KK. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma? Surg Oncol Clin N Am. 2009;18:215-24, vii. [PMID: 19306808 DOI: 10.1016/j.soc.2008.12.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wang J, Zheng C, Wang Y, Wen J, Ren H, Liu Y, Jiang H. Gene silencing of ß-catenin by RNAi inhibits cell proliferation in human esophageal cancer cells in vitro and in nude mice. Diseases of the Esophagus 2009;22:151-62. [DOI: 10.1111/j.1442-2050.2008.00875.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
7 Lepiller Q, Abbas W, Kumar A, Tripathy MK, Herbein G. HCMV activates the IL-6-JAK-STAT3 axis in HepG2 cells and primary human hepatocytes. PLoS One 2013;8:e59591. [PMID: 23555719 DOI: 10.1371/journal.pone.0059591] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
8 Nevzorova YA, Hu W, Cubero FJ, Haas U, Freimuth J, Tacke F, Trautwein C, Liedtke C. Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis. Biochim Biophys Acta. 2013;1832:1765-1775. [PMID: 23770341 DOI: 10.1016/j.bbadis.2013.06.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
9 You HL, Weng SW, Li SH, Wei YC, Sheu JJ, Chen CM, Huang WT. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma. Exp Mol Pathol. 2012;92:281-286. [PMID: 22366251 DOI: 10.1016/j.yexmp.2012.01.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
10 Fu S, Guo Y, Chen H, Xu ZM, Qiu GB, Zhong M, Sun KL, Fu WN. MYCT1-TV, a novel MYCT1 transcript, is regulated by c-Myc and may participate in laryngeal carcinogenesis. PLoS One 2011;6:e25648. [PMID: 21998677 DOI: 10.1371/journal.pone.0025648] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
11 Takahashi Y, Dungubat E, Kusano H, Ganbat D, Tomita Y, Odgerel S, Fukusato T. Application of Immunohistochemistry in the Pathological Diagnosis of Liver Tumors. Int J Mol Sci 2021;22:5780. [PMID: 34071338 DOI: 10.3390/ijms22115780] [Reference Citation Analysis]
12 Huang WS, Wang TB, He Y, Chen YJ, Zhong SL, Tan M. Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948. World J Gastroenterol 2012; 18(26): 3458-3464 [PMID: 22807617 DOI: 10.3748/wjg.v18.i26.3458] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
13 Janku F, Kaseb AO, Tsimberidou AM, Wolff RA, Kurzrock R. Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing. Oncotarget 2014;5:3012-22. [PMID: 24931142 DOI: 10.18632/oncotarget.1687] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
14 Al-Qahtani A, Al-Hazzani T, Al-hussain T, Al-Ghamdi A, Al-Mana H, Al-Arifi S, Al-Ahdal M, Aly M. Correlation between clinical characteristics, survival and genetic alterations in patients with hepatocellular carcinoma from Saudi Arabia. Cancer Genet Cytogenet 2010;203:269-77. [PMID: 21156243 DOI: 10.1016/j.cancergencyto.2010.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Huang WS, Wang JP, Wang T, Fang JY, Lan P, Ma JP. ShRNA-mediated gene silencing of β-catenin inhibits growth of human colon cancer cells. World J Gastroenterol 2007; 13(48): 6581-6587 [PMID: 18161931 DOI: 10.3748/wjg.v13.i48.6581] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
16 Luo GQ, Li JH, Cao L, Zhou YH, Wen JF. Activator protein-1 involvement in proliferation inhibition by gene silencing of Twist in gastric cancer cells. Pathology. 2011;43:697-701. [PMID: 22002117 DOI: 10.1097/pat.0b013e32834bf632] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Takahashi Y, Sheridan P, Niida A, Sawada G, Uchi R, Mizuno H, Kurashige J, Sugimachi K, Sasaki S, Shimada Y, Hase K, Kusunoki M, Kudo S, Watanabe M, Yamada K, Sugihara K, Yamamoto H, Suzuki A, Doki Y, Miyano S, Mori M, Mimori K. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC. Ann Oncol 2015;26:935-42. [PMID: 25632068 DOI: 10.1093/annonc/mdv034] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
18 Huang WS, Wang JP, Wang T, Fang JY, Lan P, Ma JP. ShRNA-mediated gene silencing of beta-catenin inhibits growth of human colon cancer cells. World J Gastroenterol. 2007;13:6581-6587. [PMID: 18161931 DOI: 10.3748/wjg.13.6581] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
19 Sun L, Nguyen AT, Spitsbergen JM, Gong Z. Myc-induced liver tumors in transgenic zebrafish can regress in tp53 null mutation. PLoS One. 2015;10:e0117249. [PMID: 25612309 DOI: 10.1371/journal.pone.0117249] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
20 Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, Frazier J, Chau BN, Loboda A, Linsley PS. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci USA. 2012;109:9545-9550. [PMID: 22623531 DOI: 10.1073/pnas.1121119109] [Cited by in Crossref: 166] [Cited by in F6Publishing: 154] [Article Influence: 16.6] [Reference Citation Analysis]
21 Ding Y, Chen B, Wang S, Zhao L, Chen J, Ding Y, Chen L, Luo R. Overexpression of Tiam1 in hepatocellular carcinomas predicts poor prognosis of HCC patients. Int J Cancer. 2009;124:653-658. [PMID: 18972435 DOI: 10.1002/ijc.23954] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
22 Chakravorty D, Jana T, Das Mandal S, Seth A, Bhattacharya A, Saha S. MYCbase: a database of functional sites and biochemical properties of Myc in both normal and cancer cells. BMC Bioinformatics 2017;18:224. [PMID: 28454513 DOI: 10.1186/s12859-017-1652-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
23 Alwahaibi NY, Budin SB, Mohamed J, Alhamdani A. Nuclear factor-kappa B as a promising target for selenium chemoprevention in rat hepatocarcinogenesis. Journal of Gastroenterology and Hepatology 2010;25:786-91. [DOI: 10.1111/j.1440-1746.2009.06160.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
24 Calvisi DF, Frau M, Tomasi ML, Feo F, Pascale RM. Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison. Biochim Biophys Acta 2012;1826:215-37. [PMID: 23393659 DOI: 10.1016/j.bbcan.2012.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 0.6] [Reference Citation Analysis]
25 Jeon J, Maeng LS, Bae YJ, Lee EJ, Yoon YC, Yoon N. Comparing Clonality Between Components of Combined Hepatocellular Carcinoma and Cholangiocarcinoma by Targeted Sequencing. Cancer Genomics Proteomics 2018;15:291-8. [PMID: 29976634 DOI: 10.21873/cgp.20087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
26 Liu X, Xiong F, Wei X, Yang H, Zhou R. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells. Cancer Sci. 2009;100:2335-2340. [PMID: 19843073 DOI: 10.1111/j.1349-7006.2009.01346.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.9] [Reference Citation Analysis]
27 Lee JY, Hong M, Lee J, Lee S, Kim KM, Park C, Lim HY. An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients. J Cancer 2017;8:730-6. [PMID: 28382134 DOI: 10.7150/jca.17887] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Frau M, Biasi F, Feo F, Pascale RM. Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. Mol Aspects Med 2010;31:179-93. [PMID: 20176048 DOI: 10.1016/j.mam.2010.02.007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 4.7] [Reference Citation Analysis]